Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma
SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma
Long-Term Remissions Shown With Chemo Plus Radiation
Raloxifene Protects Women At High or Low Risk of Disease
Study Needs 23,000 Women Whose Sisters Have Cancer
Tamoxifen: No Mortality Benefit For Most “High Risk” Women
Breast Density As Important As Age In Determining Risk
Ovariectomy Without HRT Increases Death Rate
NCI-Approved Clinical Trials
Trending Stories
- As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - mRNA vaccine for melanoma is hailed as a turning point in medicine
The data from Moderna and Merck’s trial have yet to be presented
